Kimberly J. Reidy
<p>Kimberly J. Reidy, MD, is Chief, Division of Pediatric Nephrology and Associate Professor at Children’s Hospital at Montefiore (CHAM) and Montefiore Einstein. Her clinical focus is on the treatment of hypertension and childhood-onset kidney disease. She has particular interest in nephrotic syndrome and glomerular diseases, congenital abnormalities of the kidney and urinary tract, and genetic kidney diseases.</p><p>After earning her Bachelor of Arts in chemistry at Princeton University in 1997, Dr. Reidy attended Albert Einstein College of Medicine, earning her Doctor of Medicine in 2002. Her postdoctoral training began with a pediatric internship and residency at Children’s Hospital of New York, NewYork-Presbyterian from 2002 to 2005. She then pursued a three-year National Institutes of Health (NIH) supported fellowship in pediatric nephrology at CHAM, completing it in 2008.</p><p>Dr. Reidy’s clinical research focuses on children with glomerular and chronic kidney disease, including NIH funded Nephrotic Syndrome Study Network (NEPTUNE) and Cure Glomerulonephropathy (CureGN) studies of children with nephrotic syndrome. Her translational research focuses on the effect of APOL1 risk variants on preeclampsia and perinatal outcomes. Her bench research focuses on effects of developmental genes on kidney repair and fibrosis after injury. She has shared her work through many peer-reviewed journals, invited presentations, book chapters and abstracts. Dr. Reidy is also an ad hoc reviewer for many journals including <em>Pediatric Nephrology, Kidney International and the Journal of the American Society of Nephrology</em>.</p><p>Dr. Reidy is board-certified in pediatrics and pediatric nephrology. She is an active member of several professional organizations including the American Society of Pediatric Nephrology, the American Academy of Pediatrics (AAP) and the Neonatal Kidney Collaborative. She currently serves on the Executive Committee of the Section of Nephrology for the AAP. From 2016 through 2021, she has been listed among Castle Connolly Top Doctors: New York Metro Area. In 2021, she was elected to membership in the Leo M. Davidoff Society, recognizing her long-term commitment to excellence in teaching medical students.</p>
Amanda C. Raff
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">Dr. Raff is a Professor of Medicine and the Associate Chair of Medicine for Undergraduate Medical Education. She has been the Course Director for the Einstein first year medical student Renal System Course since 2007 and the Internal Medicine Clerkship and Acting Internship Director since 2012.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">She a faculty mentor for the student led Step 1 Group near-peer evidence based guidance program and the Internal Medicine Interest Group.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">She has a clinical practice of CKD and ESRD patients and enjoys rounding on the inpatient Renal Consult and Dialysis services.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">Dr. Raff’s contributions in the field of Medical Education include serving as a Case Editor for Aquifer Internal Medicine, contributing author and reviewer for the Clerkship Directors in Internal Medicine (CDIM) curriculum revision and MKSAP 19 Nephrology section committee member.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">She has been recognized for her teaching excellence at Einstein with the Samuel M. Rosen Outstanding Teacher Award for Excellence in Basic Science Teaching, the Harry Eagle Award for Outstanding Basic Science Teaching, the Harry H. Gordon Award for Outstanding Clinical Teaching and membership in the Leo M. Davidoff Society.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">Dr. Raff received a bachelor's degree in biology from Indiana University and a MD from Albert Einstein College of Medicine. She completed a residency in Internal Medicine at NewYork Presbyterian Hospital and a chief resident year at NYU Downtown Hospital. She returned to Einstein/Montefiore for a Nephrology Fellowship and joined the Einstein Division of Nephrology faculty in 2004.</p>
Autosomal Dominant Polycystic Kidney Disease (ADPKD)<br />Chronic Kidney Disease (CKD)<br />End Stage Kidney Disease (ESKD, ESRD)<br />Acute Kidney Injury (AKI)<br />Glomerular diseases<br />Hypertension<br />Electrolyte Disorders<br />Kidney Stones<br />
<p><span style="color:black;"> </span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">1. </span><span style="font-size: 12pt; font-family: Cambria; color: #212121;">Fitz M, Adams W, Haist S, Hauer K, Ross P, <strong>Raff A</strong>, Agarwal G, Vu T, Appelbaum J, Lang V, Miller C, Grum C and the Clerkship Directors in Internal Medicine – National Board of Medical Examiners EXPRESS Study Group. Which Internal Medicine Clerkship Characteristics Are Associated With Students' Performance on the NBME Medicine Subject Exam? A Multi-Institutional Analysis. <em>Acad Med</em>. 2020;10.1097/ACM.0000000000003322 [published online ahead of print, 2020 Mar 17]. </span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria; color: #212121;">2. </span><span style="font-size: 12pt; font-family: Cambria;">Brien K (Author), Calvo L (Associate editor), <strong>Raff A</strong> (Case editor). <em>Aquifer Internal Medicine Case 33: 49-year-old woman with confusion</em>. 2019 </span><u><span style="font-size: 12pt; font-family: Cambria; color: #3366ff;">https://www.aquifer.org</span></u></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria; color: #212121;">3. </span><span style="font-size: 12pt; font-family: Cambria;">Khan M, Gil N, Lin W, Fiter R, Kenawy D, Burton W, <strong>Raff A</strong>. The impact of Step 1 scores on medical students’ residency specialty choice. <em>Med Sci Educ.</em> 28(4): 699-705. 2018.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">4. Ludwig A, <strong>Raff A</strong>, Lin J, Schoenbaum E. Group Observed Structured Encounter (GOSCE) for third year medical students improves self-assessment of clinical communication. <em>Medical Teacher</em> 39(9): 931-5. 2017.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">5. Golestaneh L, Neugarten J, Southern W, Kargoli F, <strong>Raff A</strong>. Improving the diagnostic workup of hyponatremia in the setting of kidney disease: a continuing medical education (CME) initiative. <em>Int Urol Nephrol</em> 49(3): 491-7. 2017</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">6. Czapka M, <strong>Raff A</strong>, Risley M. Safe Transitions: An active learning module for discharge summaries and interprofessional care. <em>MedEdPORTAL iCollaborative</em>. 2017</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">7. Tanenbaum, E, Johnson J, Jordan, E, Cottral J, Tenore C, Burton W, McGinn A<strong>, Raff A</strong>. An effective evidence-based student run near-peer support group for the USMLE Step 1 Exam. <em>Med Sci Educ</em>. 26(4): 691-9. 2016</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">8. Ludwig A, Lee R, Parish S, <strong>Raff A</strong>. Four-station group observed structured clinical encounter for formative assessment of communication skills for internal medicine clerks. <em>MedEdPORTAL Publications</em>. 12:10444. 2016 </span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">9. Chen W, Melamed M, Hostetter T, Bauer C, <strong>Raff A</strong>, Almudevar A, Lalonde A, Messing S, Abramowitz M. Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study. <em>BMC Nephrol</em>. 17(1): 114. doi: 10.1186/s12882-016-0331-6. 2016</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">10. Jion Y, <strong>Raff A</strong>, Grosberg B, Evans R. The risk and management of kidney stones from the use of topiramate and zonisamide in migraine and idiopathic intracranial hypertension. <em>Headache</em>. 55(1): 161-6. 2015</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">11. Jion Y, <strong>Raff A</strong>, Grosberg B, Evans R. Topiramate and nephrolithiasis: a response. <em>Headache</em>. 55(5): 710-2. 2015</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">12. Abramowitz, M, Melamed M, Bauer C, <strong>Raff A</strong>, Hostetter T. Effects of oral sodium bicarbonate in patients with CKD. <em>Clin J Am Soc Nephrol</em>. 8(5): 714-20. 2013</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">13. Berman N, Lectura M, Thurman J, Reinecke J, <strong>Raff A</strong>, Melamed M, Quan Z, Evans T, Meyer T, Hostetter T. A zebrafish model for uremic toxicity: role of the complement pathway. <em>Blood Purif</em>. 35(4): 265-9. 2013</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">14. Bomback A, <strong>Raff A</strong>. Olfactory function in dialysis patients: a potential key to understanding the uremic state. <em>Kidney Int</em>. 80(8): 803-5. 2011</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">15. Ponda M, Quan Z, Melamed M, <strong>Raff A</strong>, Meyer T, Hostetter T. Methylamine clearance by haemodialysis is low. <em>Nephrol Dial Transplant</em>. 25(5): 1608-13. 2010</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">16. <strong>Raff A</strong>, Lieu S, Melamed M, Quan Z, Ponda M, Meyer T, Hostetter T. Relationship of Impaired Olfactory Function in ESRD to Malnutrition and Retained Uremic Molecules. <em>Am J Kidney Dis</em>. 52(1): 102-10. 2008</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">17. <strong>Raff A</strong>, Meyer T, Hostetter T. New Insights into uremic toxicity. <em>Curr Opin Nephrol Hypertens</em>. 17(6): 560-5. 2008</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">18. Susztak K, <strong>Raff A</strong>, Schiffer M, Bottinger E. Glucose – induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. <em>Diabetes</em>. 55(1): 225-33. 2006</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">19. Schiffer M. Susztak K, Ranalletta M, <strong>Raff A</strong>, Bottinger E, Charron M. Localization of the GLUT8 transporter in murine kidney and regulation in vivo in non-diabetic and diabetic conditions. <em>Am J Physiol Renal Physiol</em>, 289(1): F186-193. 2005</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">20. <strong>Raff A</strong>, Hebert T, Pullman J, Coco M. Crescentic post-streptococcal glomerulonephritis with nephrotic syndrome in the adult: is aggressive therapy warranted? <em>Clinical Nephrology</em>, 63(5): 375-380. 2005</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">21. Spector M, <strong>Raff A</strong>, DeSilva H, Lee K, Osley M. Hir1p and Hir2p function as transcriptional corepressors to regulate histone gene transcription in <em>Saccharomyces cerevisiae </em>cell cycle. <em> Molecular and Cellular Biology</em>, 17(2): 545-552. 1997</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">22. Recht J, Dunn B, <strong>Raff A</strong>, Osley M. Functional analysis of histone H2A and H2B in transcriptional repression in <em>Saccharomyces cerevisiae. Molecular and Cellular Biology</em>, 16(6): 2545-2553<em>.</em> 1996</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">23. Kopczynski J, <strong>Raff A</strong>, Bonner J. Translational readthrough at nonsense mutations in the <em>HSF1</em> gene of <em>Saccharomyces cerevisiae. </em> <em>Molecular and General Genetics</em>, 234: 369-378. 1992</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: 'Times New Roman';"> </span></p>
<p>Amanda C. Raff, MD, is Attending Physician, Professor and Associate Chair of Medicine for Undergraduate Medical Education at Montefiore-Einstein. She is also the co-director of the Montefiore-Einstein Autosomal Dominant Polycystic Kidney Disease Program. Dr. Raff’s clinical focus is on dialysis and the treatment of patients with chronic kidney disease and end stage kidney disease.</p><p>After earning her Bachelor of Science in biology at Indiana University, Dr. Raff completed her Doctor of Medicine at Albert Einstein College of Medicine, earning her degree in 1998. Her postdoctoral training began at New York Presbyterian Hospital with an internship and residency in internal medicine from 1998 through 2001. She was assistant chief resident at Memorial Sloan Kettering Cancer Center in 2000 and chief resident at New York University Downtown Hospital from 2001 to 2002. She then returned to Montefiore-Einstein to complete a two-year fellowship in nephrology in 2004.</p><p>Dr. Raff’s research focuses on medical education. She has been the Course Director for the Einstein medical student Renal Course since 2007 and the Internal Medicine Clerkship and Acting Internship Director since 2012. Dr. Raff’s contributions in the field of Medical Education include serving as a Nephrology section committee member for the American College of Physicians’ Medical Knowledge Self-Assessment Program (MKSAP) 19 and 20 as well as prior work as a Case Editor for Aquifer Internal Medicine and contributing author and reviewer for the Clerkship Directors in Internal Medicine (CDIM) curriculum revision.</p><p>An enthusiastic medical educator, Dr. Raff has received several awards for her teaching and in 2010 was inducted into the Leo M. Davidoff Society for outstanding achievement in the teaching of medical students. She is board certified and is a member the American Society of Nephrology and a fellow of the American College of Physicians.</p>
Cindy T. Pynadath
Kidney and Pancreas Transplantation
Dr. Pynadath’s current research interest in Transplant Medicine explores its connection to infectious disease and mineral bone and metabolic disorders, as well as the clinical outcomes in kidney transplant. Her work collaborations have been published in reputed journals, as well as presented at national and international transplant conferences.
<p>Cindy T. Pynadath, DO, is a Transplant Nephrologist and Assistant Professor, Medicine at Montefiore Einstein. Her clinical focus centers on kidney and pancreas transplantation.</p><p>After obtaining her Bachelor of Science in integrated life sciences from Kent State University in 2005, Dr. Pynadath earned her Doctor of Osteopathic Medicine at Ohio University College of Osteopathic Medicine in 2009. She then completed her internal medicine residency at the Cleveland Clinic Foundation in 2012 before completing a nephrology fellowship at University Hospitals Case Medical Center in 2014. Following this, Dr. Pynadath completed a transplant nephrology fellowship at the same institution in 2015.</p><p>Dr. Pynadath’s current research in transplant medicine explores its connection to infectious disease and mineral bone and metabolic disorders, as well as the clinical outcomes in kidney transplantation. Her work collaborations have been published in a number of reputed journals, as well as presented at national and international transplant conferences.</p><p>Dr. Pynadath is board certified by the American Board of Internal Medicine. She is a member of multiple professional associations including the American Society of Transplantation (AST) and the American Society of Nephrology (ASN). She is a past recipient of the Caregiver Celebrations Appreciation Award for exemplary clinical and patient care from the Cleveland Clinic Foundation.</p>
James M. Pullman
Advanced microscopy technology including computational microscopy
Joel Neugarten
<p>Acute and Chronic Kidney Disease<span style="font-size:10.5pt;font-family:'Arial',sans-serif;color:#5B5B5B;"></span></p>
Dr. Neugarten's main research interest is investigating mechanisms of acute and chronic kidney injury
<p><ol>
<li>Neugarten J. Estrogen and oxidative stress. Gend Med. Mar;4(1):31-2. 2007.</li>
<li>Silbiger S, Neugarten J. Gender and human renal disease. Gend Med.5: Suppl A:S3-S10. Review</li>
<li>Neugarten J: Estrogen and reactive oxygen species. Gender Med. . 2008</li>
</ol></p>
Dr. Joel Neugarten is currently Professor of Medicine at the Albert Einstein College of Medicine, Medical Director of the Bedford Park Dialysis Unit, and an Attending Nephrologist at Montefiore Medical Center in the Bronx, New York. He is a graduate of the Albert Einstein College of Medicine and the Brooklyn Law School and completed his post graduate training at Mount Sinai Medical Center in New York and at New York University Medical Center. He previously served as Site Director of the Nephrology Division of Montefiore Medical Center and as President of the New York Society of Nephrology. He is an author of over 100 peer reviewed publications and book chapters dealing with numerous aspects of Nephrology. His major research interests include factors that influence the progression of chronic kidney disease and the management of patients with chronic kidney disease.
Tina M. Neade
Chronic kidney disease, Glomerular disease, End stage renal disease, Kidney stones and Hypertension
Tina Neade, M.D., is an Assistant Professor of Medicine in the Division of Nephrology at Montefiore Medical Center/ Albert Einstein College of Medicine. She earned her medical degree at Albert Einstein College of Medicine, New York in 2002. She then completed her internal medicine residency at Mount Sinai Hospital in New York in 2005, followed by a nephrology fellowship at Mount Sinai Hospital in 2008. Dr Neade joined the faculty at Montefiore Medical Center in 2017. Dr. Neade is board certified in Internal Medicine and Nephrology.
Shrivatsa Nadiger
Kerry A. Morrone
<p>Anemia, hospitalist medicine, general pediatrics</p>
Dr. Morrone focuses on classical hematology, particularly sickle cell disease and hemoglobinopathies, platelet disorders, thrombosis, and bone marrow failure syndromes.
Dr. Morrone is committed to improving quality of care and health care utilization in chronic illness, particularly sickle cell disease, and thalassemia through her research
<p>Kerry Morrone, MD, is an Assistant Professor of Pediatrics at the Albert Einstein College of Medicine, the Director of the Sickle Cell Program and the Director of the Pediatric Hematology Oncology Fellowship Program at Montefiore. Dr. Morrone focuses on classical hematology, particularly sickle cell disease and hemoglobinopathies, platelet disorders, thrombosis, and bone marrow failure syndromes.</p><p>Dr. Morrone graduated from New York University, earning her Bachelor of Arts in Biology in 2003. She then attended the Albert Einstein College of Medicine, where she received her Doctor of Medicine in 2007 and was inducted into the Alpha Omega Alpha Honor Medical Society. Dr. Morrone completed her pediatric residency, chief residency, and pediatric hematology oncology fellowship all at the Albert Einstein College of Medicine. She has also been recognized for her teaching efforts many times and won the Leo M. Davidoff Society – Albert Einstein College of Medicine Teaching Award in 2010 and 2015.</p><p>Dr. Morrone is committed to improving quality of care and health care utilization in chronic illness, particularly sickle cell disease, and thalassemia through her research. Other current research interests include pulmonary complications of sickle cell disease particularly asthma and acute chest syndrome, in addition to infectious complications and thrombotic complications of sickle cell disease.</p>
Michal L. Melamed
<p>Dr. Michal Melamed is a Professor of Medicine and Epidemiology & Population Health at the Albert Einstein College of Medicine. She has been the Nephrology Fellowship Program Director since 2012. After completing her undergraduate degree in Dramatic Literature at New York University <em>summa cum laude</em>, she trained at Johns Hopkins School of Medicine for medical school, Internal Medicine residency, and Nephrology fellowship. Additionally, she completed a Masters in Clinical Epidemiology from the Johns Hopkins Bloomberg School of Public Health during her fellowship.</p>
<p>She has been continuously funded by the National Institutes of Health since 2007 and her research interests include the epidemiology of chronic kidney disease and its complications, the epidemiology and health consequences of Vitamin D deficiency and metabolic acidosis. Dr. Melamed is the Principal Investigator of several NIH-funded research studies. She has published over 90 original publications in the medical literature and has mentored countless young investigators from high school students to junior faculty members. In 2019, she won the Distinguished Mentor Award from the American Society of Nephrology.</p>
<p> </p>
<p>Selected Publications:<br /> <br /><strong>Melamed ML</strong>, Eustace JA, Plantinga L, Jaar BG, Fink NE, Klag MJ, Coresh J, Powe NR. Changes in Serum Calcium, Phosphate and PTH and the Risk of Death in Incident Dialysis Patients: A Longitudinal Study. Kidney Int 2006 Jul;70(2):351-7.<br /> <br />Gupta R, Plantinga LC, Fink NE, <strong>Melamed ML</strong>, Coresh J, Fox CS, Levin NW, Powe NR. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA 2007 Apr 4;297(13):1455-64.<br /> <br />Hailpern SM, <strong>Melamed ML</strong>, Cohen HW, Hostetter T. Moderate Chronic Kidney Disease and Cognitive Function in Adults 20-59 Years of Age (NHANES III). J Am Soc Nephrol 2007 Jul;18(7):2205-13.<br /> <br /><strong>Melamed ML,</strong> Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR. Third-Generation Parathyroid Hormone Assays and All-Cause Mortality in Incident Dialysis Patients: The CHOICE Study. Nephrol Dial Transplant. 2008 May; 23(5):1650-8.</p>
<p><strong>Melamed ML*, </strong>Muntner P*, Michos ED, Uribarri J, Weber C, Sharma J, Raggi P. Serum 25-hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001-2004. Atheroscler Thromb Vasc Biol. 2008 Jun;28(6)1179-85.<br /> <br /><strong>Melamed ML*, </strong>Michos ED*, Post W, Astor B. 25-Hydroxyl Vitamin D Levels and the Risk of Mortality in the General Population. Arch Intern Med. 2008 Aug 11;168(15):1629-37.<br /> <br />Shah S, Abramowitz M, Hostetter TH, <strong>Melamed ML</strong>. Serum Bicarbonate Levels and the Progression of Kidney Disease: A Cohort Study. Am J Kidney Dis. 2009 Aug;54(2):270-7.<br /> <br />Kumar J, Muntner P, Kaskel FJ, Hailpern SM, <strong>Melamed ML</strong>. Prevalence and Associations of 25- Hydroxyvitamin D Deficiency in Children and Adolescents in the United States: Results from NHANES 2001-2004. Pediatrics. Aug 3 2009. Electronic pages.<br /> <br />Plantinga LC, Fink NE, Coresh J, Sozio SM, Parekh RS, <strong>Melamed ML</strong>, Powe NR, Jaar BG. Peripheral vascular disease-related procedures in dialysis patients: predictors and prognosis. Clin J Am Soc Nephrol. 2009 Oct;4 (10):1637-45.<br /> <br />Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, <strong>Melamed ML</strong>, Wiebe N, Muntner P. Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality. Circulation. 2009 Oct. 19 Epub. 2009 Nov 3;120(18):1784-92.<br /> <br /><strong>Melamed ML</strong>, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P. 25-Hydroxyvitamin D levels, Race and the Progression of Kidney Disease. J Am Soc Nephrol. 2009 Dec.;20(12) 2631-9.<br /> <br />Abramowitz M, Muntner P, Coco M, Southern W, Lotwin I, Hostetter TH, <strong>Melamed ML</strong>. Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization. Clin J Am Soc Nephrol. 2010 Apr 8 Epub. 2010 Jun;5(6):1064-71.<br /> <br />Murea M, Park JK, Sharma S, Kato H, Gruenwald A, Niranjan T, Si H, Thomas DB, Pullman JM, <strong>Melamed ML</strong>, Susztak K. Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int. 2010 June 9; 78(5):514-22.<br /> <br /><strong>Melamed ML, </strong>Blackwell T, Neugarten J, Arnsten J, Ensrud K, Ishani A, Cummings S, Silbiger S. Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis. Kidney Int. 2011 Jan;79(2):241-9<br /><strong> </strong><br />O’ Seaghdha CM, Hwang S-J, Muntner P, <strong>Melamed ML</strong>*, Fox CS*. Serum phosphorus predicts incident Chronic Kidney Disease and End-Stage Renal Disease. Nephrol Dial Transplant 2011 Sep;26(9):2885-90. Epub 2011 Feb 3.<br /> <br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. Association of Serum Bicarbonate Levels with Gait Speed and Quadriceps Strength in Older Adults. Am J Kidney Dis 2011 Feb 25.<br /> <br />Sharief S, Jariwala S, Kumar J, Muntner P, <strong>Melamed ML</strong>. Vitamin D levels and food and environmental allergies in the United States: Results from NHANES 2005-6. Journal of Allergy and Clinical Immunology 2011 May;127(5):1195-202. Epub 2011 Feb 16. PMID: 21329969<br /> <br />Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, <strong>Melamed ML</strong>. Association of Glucocorticoid Use and Low 25-Hydroxyvitamin D Levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab. 2011 Sept 28. (Epub)<br /> <br />Michos ED, Reis JP, Post WS, Lutsey PL, Gottesman RF, Mosley TH, Sharrett AR, <strong>Melamed ML</strong>. 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES III linked mortality files. Nutrition 2012 Apr; 28(4)367-71.<br /> <br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adults. Kidney International. 2012 May;81(10):103342. Epub 2012 Feb 1. PMCID: PMC3340439<br /> <br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. The serum anion gap is altered in early kidney disease and associates with mortality. Kidney International. 2012 Sep;82 (6):701-9.<br /> <br />Abramowitz MK, <strong>Melamed ML</strong>, Bauer C, Raff AC, Hostetter TH. Effects of Oral Sodium Bicarbonate in Patients with CKD. Clinical Journal of the American Society of Nephrology. 2013 Feb 7<sup>th</sup> Epub ahead of print. 2013 May; 8(5)714-20.<br /><br /><strong>Melamed ML</strong>, Plantinga L, Shafi T, Parekh R, Meyer TW, Hostetter TH, Coresh J, Powe NR. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators. BMC Nephrol 2013 June 27;14(1)134.<br /> <br />Milman S, Schulder-Katz M, Deluty J, Zimmerman ME, Crandall JP, Barzilai N, <strong>Melamed ML*</strong>, Atzmon G*. Individuals with Exceptional Longevity Manifest a Delayed Association Between Vitamin D Insufficiency and Cognitive Impairment. J Am Geriatr Soc. 2014 Jan Epub.<br /> <br />Akchurin OM, <strong>Melamed ML</strong>, Hashim BL, Kaskel FJ, Del Rio M. Medication adherence in the transition of adolescent kidney transplant recipients to the adult care. Pediatric Transplantation. 2014 May 12 Epub. 18(5):538-48.<br /> <br />Chen W, <strong>Melamed ML</strong>, Abramowitz MK. Serum bicarbonate and Bone Mineral Density in US Adults. Am J Kidney Dis. 2014 Aug 26 Epub. 2015 Feb;65(2):240-8. <br /> <br />Sarathy H, Pramanik V, Kahn J, Abramowitz MK, Meier K, Kishore P, <strong>Melamed ML</strong>. The Effects of Short-term Vitamin D Supplementation on Glucose Metabolism in Dialysis Patients: A Systematic Review and Meta-Analysis. Int Urol Nephrol. 2015 Mar;47(3):537-49. <br /> <br />Barry EL, Mott LA, <strong>Melamed ML,</strong> Rees JR, Ivanova A, Sandler RS, Ahnen DJ, Bresalier RS, Summers RW, Bostick RM, Baron JA. Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One. 2014. Oct 15;9(10):e108094.<br /> <br />Calp-Inal S, Ajaimy M, <strong>Melamed ML</strong>, Savchik C, Masiakos P, Colovai A, Akalin E. The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation. Kidney Int 2015 Nov 4 (Epub ahead of print)<br /> <br />Kumar J, McDermott K, Abraham AG, Friedman LA, Johnson VL, Kaskel FJ, Furth SL, Warady BA, Portale AA, <strong>Melamed ML. </strong>Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKID) cohort. Pediatr Nephrol. 2016 Jan; 31(1):121-9.</p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-no-proof: yes;">Chen W, <strong>Melamed ML</strong>, Hostetter TH, Bauer C, Raff AC, Almudevar AL, Lalonde A, Messing S, Abramowitz MK. Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study. <em>BMC Nephrol. </em>2016;17(1):114.</span></p>
<p><span style="text-indent: -0.25in; font-size: 11pt; font-family: Arial, sans-serif;">Shafi T, Powe NR, Meyer TW, Hwang S, Hai X, <strong>Melamed ML</strong>, Banerjee T, Coresh J, Hostetter TH. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. <em>J Am Soc Nephrol. </em>2017 Jan;28(1):321-31.</span></p>
<p><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-bidi-font-weight: bold;">Goel N, Kwon C, Zachariah TP, Broker M, Folkert VW, Bauer C, <strong>Melamed ML</strong>. Vascular access placement in patients with chronic kidney disease stages 4 and 5 attending an inner city nephrology clinic: a cohort study and survey of providers. <em>BMC Nephrol</em>. 2017; 18(1):28.</span></p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">Buttar RS, Batra J, Kreimerman J, Aleta M, <strong>Melamed ML</strong>. Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels. J Gen Intern Med. 2017 Oct;32(10):1156-1159.</span></p>
<p><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-bidi-font-weight: bold;">Golestaneh L Bellin E, Southern W, <strong>Melamed ML</strong>. Discharge service as a determinant of 30-day readmission in a cohort of maintenance hemodialysis patients: a retrospective cohort study. BMC Nephrol. 2017 Dec 4;18(1):352.</span></p>
<p><strong><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">Melamed ML</span></strong><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">, Chonchol M, Gutierrez OM, Kalantar-Zadeh K, Kendrick J, Norris K, Scialla JJ, Thadhani R. The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2018; 72(6)834-845.</span></p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">Astor BC, Djamali A, Mandelbrot DA, Parajuli S, <strong>Melamed ML</strong>. The Association of 25-hydroxyvitamin D Levels with Late Cytomegalovirus Infection in Kidney Transplant Recipients: the Wisconsin Allograft Recipient Database (WisARD). Transplantation</span> <span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">2019 Aug;103(8):1683-1688</span></p>
<p><span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Chen W, Eisenberg R, Mowrey WB, Wylie-Rosett J, Abramowitz MK, Bushinsky DA, <strong>Melamed ML</strong>. Association between dietary zinc intake and abdominal aortic calcification in US adults. Nephrol Dial Transplant. 2019 Jul 11.</span></span></p>
<p><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">Sochol KM, Johns TS, Buttar RS, Randhawa L, Sanchez E, Gal M, Lestrade K, Merzkani M, Abramowitz MK, Mossavar-Rahmani Y, </span><strong style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">Melamed ML</strong><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">. The Effects of Dairy Intake on Insulin Resistance: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients 2019; 11(9):2237.</span></p>
<p><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;"><strong>Melamed ML</strong>, Horwitz EJ, Dobre MA, Abramowitz MK, Zhang L, Lo Y, Mitch WE, Hostetter TH. The Effects of Sodium Bicarbonate in Chronic Kidney Disease Stages 3 and 4: A Randomized, Placebo-Control, Multi-Center Clinical Trial. American Journal of Kidney Diseases. 2020.</span></p>
<p> </p>